241 related articles for article (PubMed ID: 27142487)
21. Pathophysiology of gene-targeted mouse models for cystic fibrosis.
Grubb BR; Boucher RC
Physiol Rev; 1999 Jan; 79(1 Suppl):S193-214. PubMed ID: 9922382
[TBL] [Abstract][Full Text] [Related]
22. CFTR: cystic fibrosis and beyond.
Mall MA; Hartl D
Eur Respir J; 2014 Oct; 44(4):1042-54. PubMed ID: 24925916
[TBL] [Abstract][Full Text] [Related]
23. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
Kuk K; Taylor-Cousar JL
Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
[TBL] [Abstract][Full Text] [Related]
24. Early intrahepatic duct defects in a cystic fibrosis porcine model.
Zarei K; Meyerholz DK; Stoltz DA
Physiol Rep; 2021 Jul; 9(14):e14978. PubMed ID: 34288572
[TBL] [Abstract][Full Text] [Related]
25. Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies.
Kukavica-Ibrulj I; Levesque RC
Lab Anim; 2008 Oct; 42(4):389-412. PubMed ID: 18782827
[TBL] [Abstract][Full Text] [Related]
26. Bioelectric properties of chloride channels in human, pig, ferret, and mouse airway epithelia.
Liu X; Luo M; Zhang L; Ding W; Yan Z; Engelhardt JF
Am J Respir Cell Mol Biol; 2007 Mar; 36(3):313-23. PubMed ID: 17008635
[TBL] [Abstract][Full Text] [Related]
27. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.
Jiang Q; Engelhardt JF
Eur J Hum Genet; 1998 Jan; 6(1):12-31. PubMed ID: 9781011
[TBL] [Abstract][Full Text] [Related]
28. Mouse models of cystic fibrosis: phenotypic analysis and research applications.
Wilke M; Buijs-Offerman RM; Aarbiou J; Colledge WH; Sheppard DN; Touqui L; Bot A; Jorna H; de Jonge HR; Scholte BJ
J Cyst Fibros; 2011 Jun; 10 Suppl 2():S152-71. PubMed ID: 21658634
[TBL] [Abstract][Full Text] [Related]
29. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
[TBL] [Abstract][Full Text] [Related]
30. Molecular modelling approaches for cystic fibrosis transmembrane conductance regulator studies.
Odolczyk N; Zielenkiewicz P
Int J Biochem Cell Biol; 2014 Jul; 52():39-46. PubMed ID: 24735712
[TBL] [Abstract][Full Text] [Related]
31. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic pathophysiology in cystic fibrosis.
Gibson-Corley KN; Meyerholz DK; Engelhardt JF
J Pathol; 2016 Jan; 238(2):311-20. PubMed ID: 26365583
[TBL] [Abstract][Full Text] [Related]
33. Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator.
Tirkos S; Newbigging S; Nguyen V; Keet M; Ackerley C; Kent G; Rozmahel RF
Respir Res; 2006 Mar; 7(1):51. PubMed ID: 16571124
[TBL] [Abstract][Full Text] [Related]
34. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
[TBL] [Abstract][Full Text] [Related]
35. Lung arginase expression and activity is increased in cystic fibrosis mouse models.
Jaecklin T; Duerr J; Huang H; Rafii M; Bear CE; Ratjen F; Pencharz P; Kavanagh BP; Mall MA; Grasemann H
J Appl Physiol (1985); 2014 Aug; 117(3):284-8. PubMed ID: 24925982
[TBL] [Abstract][Full Text] [Related]
36. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model.
Durie PR; Kent G; Phillips MJ; Ackerley CA
Am J Pathol; 2004 Apr; 164(4):1481-93. PubMed ID: 15039235
[TBL] [Abstract][Full Text] [Related]
37. Airway acidification initiates host defense abnormalities in cystic fibrosis mice.
Shah VS; Meyerholz DK; Tang XX; Reznikov L; Abou Alaiwa M; Ernst SE; Karp PH; Wohlford-Lenane CL; Heilmann KP; Leidinger MR; Allen PD; Zabner J; McCray PB; Ostedgaard LS; Stoltz DA; Randak CO; Welsh MJ
Science; 2016 Jan; 351(6272):503-7. PubMed ID: 26823428
[TBL] [Abstract][Full Text] [Related]
38. Abnormal enamel development in a cystic fibrosis transgenic mouse model.
Wright JT; Kiefer CL; Hall KI; Grubb BR
J Dent Res; 1996 Apr; 75(4):966-73. PubMed ID: 8708137
[TBL] [Abstract][Full Text] [Related]
39. The Gut-Lung Axis in Cystic Fibrosis.
Price CE; O'Toole GA
J Bacteriol; 2021 Sep; 203(20):e0031121. PubMed ID: 34339302
[TBL] [Abstract][Full Text] [Related]
40. Mild processing defect of porcine DeltaF508-CFTR suggests that DeltaF508 pigs may not develop cystic fibrosis disease.
Liu Y; Wang Y; Jiang Y; Zhu N; Liang H; Xu L; Feng X; Yang H; Ma T
Biochem Biophys Res Commun; 2008 Aug; 373(1):113-8. PubMed ID: 18555011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
